UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028279
Receipt number R000032372
Scientific Title A follow-up study to evaluate the infant skin condition in summer
Date of disclosure of the study information 2017/08/10
Last modified on 2021/01/19 09:58:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A follow-up study to evaluate the infant skin condition in summer

Acronym

A study to evaluate the infant skin condition

Scientific Title

A follow-up study to evaluate the infant skin condition in summer

Scientific Title:Acronym

A study to evaluate the infant skin condition

Region

Japan


Condition

Condition

Healthy infants

Classification by specialty

Dermatology Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Understandings of skin condition

Basic objectives2

Others

Basic objectives -Others

Observational Study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Measurement of infant skin condition

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

12 months-old <=

Age-upper limit

24 months-old >=

Gender

Male and Female

Key inclusion criteria

Healthy infants

Key exclusion criteria

1. Infant with chronic sickness.
2. Infant with the severe skin symptoms who needs treatment of an atopic dermatitis et al.
3. The infant infected with a disease of infectibility disease.
4. The infant who judged that a test doctor in attendance was unsuitable as a test participant.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Yasuyuki
Middle name
Last name Okuda

Organization

Kao Corporation

Division name

R&D - Development Research - Sanitary Products Research

Zip code

321-3497

Address

2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN

TEL

0285-68-7432

Email

okuda.yasuyuki@kao.co.jp


Public contact

Name of contact person

1st name Jun
Middle name
Last name Kajiwara

Organization

Kao Corporation

Division name

R&D - Development Research - Sanitary Products Research

Zip code

321-3497

Address

2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN

TEL

0285-68-7379

Homepage URL


Email

kajiwara.jun@kao.co.jp


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

Tel

+81-3-5630-9220

Email

uesaka.toshio@kao.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

DRC株式会社(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 07 Month 10 Day

Date of IRB

2017 Year 07 Month 10 Day

Anticipated trial start date

2017 Year 08 Month 18 Day

Last follow-up date

2018 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2021 Year 01 Month 19 Day


Other

Other related information

Measurement of infant skin condition


Management information

Registered date

2017 Year 07 Month 19 Day

Last modified on

2021 Year 01 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032372


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name